Clinical Chemistry Siemens Point of Care - Urinalysis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 54: 1379-1385, 2008. First published June 6, 2008; 10.1373/clinchem.2008.103556
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
clinchem.2008.103556v1
54/8/1379    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Geistanger, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Geistanger, A.
Related Collections
Right arrow Informatics and Statistics
(Clinical Chemistry. 2008;54:1379-1385.)
© 2008 American Association for Clinical Chemistry, Inc.

Informatics and Statistics

Statistical Methods for Monitoring the Relationship between the IFCC Reference Measurement Procedure for Hemoglobin A1c and the Designated Comparison Methods in the United States, Japan, and Sweden

Andrea Geistanger1,a, Sabine Arends1, Christoph Berding1, Tadao Hoshino2, Jan-Olof Jeppsson3, Randie Little4, Carla Siebelder5, Cas Weykamp5 on behalf of the IFCC Working Group on Standardization of Hemoglobin A1c

1 Roche Diagnostics GmbH, Department of Biostatistics, Penzberg, Germany; 2 Institute of Biopathological Medicine, Kanagawa, Japan; 3 Malmoe University Hospital, Malmoe, Sweden; 4 University of Missouri School of Medicine, Columbia, MO; 5 Queen Beatrix Hospital, Winterswijk, The Netherlands.

aAddress correspondence to this author at: Roche Diagnostics GmbH, Department of Biostatistics, Nonnenwald 2, 82377 Penzberg, Germany. Fax +49 8856 604152; e-mail andrea.geistanger{at}roche.com.

Background: The American Diabetes Association (ADA)/European Association for the Study of Diabetes (EASD)/International Diabetes Federation (IDF)/IFCC Consensus Statement on the worldwide standardization of HbA1c states that "... [HbA1c] results are to be reported world-wide in IFCC units ... and derived NGSP units ... , using the IFCC-NGSP master equation."

Methods: We describe statistical methods to evaluate and monitor the relationships as expressed in master equations (MEs) between the IFCC Reference Measurement procedure (IFCC-RM) and designated comparison methods (DCMs) [US National Glycohemoglobin Standardization Program (NGSP), Japanese Diabetes Society/Japanese Society for Clinical Chemistry (JDS/JSCC), and Mono-S in Sweden]. We applied these statistics, including uncertainty calculations, to 12 studies in which networks of reference laboratories participated, operating the IFCC-RM and DCMs.

Results: For NGSP and Mono-S, slope, intercept, and derived percentage HbA1c at the therapeutic target show compliance with the respective MEs in all 12 studies. For JDS/JSCC, a slight deviation is seen in slope and derived percentage HbA1c in 2 of the 12 studies. Using the MEs, the uncertainty in an assigned value increases from 0.42 mmol/mol HbA1c (IFCC-RM) to 0.47 (NGSP), 0.49 (JDS/JSCC), and 0.51 (Mono-S).

Conclusions: We describe sound statistical methods for the investigation of relations between networks of reference laboratories. Application of these statistical methods to the relationship between the IFCC-RM and DCMs in the US, Japan, and Sweden shows that they are suitable for the purpose, and the results support the applicability of the ADA/EASD/IDF/IFCC Consensus Statement on HbA1c measurement.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Association for Clinical Chemistry.